Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Amyloidosis Therapy
Studies from University of Medicine and Dentistry of New Jersey, Department of Medicine yield new data on amyloidosis therapy
May 18th, 2008
Researchers detail in 'Gastrointestinal manifestations of amyloidosis,' new data in amyloidosis. "Amyloidosis is characterized by extracellular deposition of abnormal protein. There are six types: primary, secondary, hemodialysis-related, hereditary, senile, and localized," researchers in the United States report. "Primary (AL) amyloidosis is associated with monoclonal light chains in serum and/or urine with 15% of patients having multiple myeloma. Secondary (AA) amyloidosis is associated with inflammatory, infectious, and neoplastic diseases. The presentation is protean, including macroglossia, a dilated and atonic esophagus, gastric polyps or enlarged folds, and...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-18)
|
